MX2015003564A - Composiciones y metodos de uso de un compuesto de control de inapetencia. - Google Patents
Composiciones y metodos de uso de un compuesto de control de inapetencia.Info
- Publication number
- MX2015003564A MX2015003564A MX2015003564A MX2015003564A MX2015003564A MX 2015003564 A MX2015003564 A MX 2015003564A MX 2015003564 A MX2015003564 A MX 2015003564A MX 2015003564 A MX2015003564 A MX 2015003564A MX 2015003564 A MX2015003564 A MX 2015003564A
- Authority
- MX
- Mexico
- Prior art keywords
- inapetence
- compositions
- methods
- livestock
- control composite
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/111—Aromatic compounds
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/116—Heterocyclic compounds
- A23K20/132—Heterocyclic compounds containing only one nitrogen as hetero atom
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/116—Heterocyclic compounds
- A23K20/137—Heterocyclic compounds containing two hetero atoms, of which at least one is nitrogen
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K50/00—Feeding-stuffs specially adapted for particular animals
- A23K50/10—Feeding-stuffs specially adapted for particular animals for ruminants
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K50/00—Feeding-stuffs specially adapted for particular animals
- A23K50/20—Feeding-stuffs specially adapted for particular animals for horses
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K50/00—Feeding-stuffs specially adapted for particular animals
- A23K50/40—Feeding-stuffs specially adapted for particular animals for carnivorous animals, e.g. cats or dogs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Polymers & Plastics (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Husbandry (AREA)
- Zoology (AREA)
- Food Science & Technology (AREA)
- Epidemiology (AREA)
- Birds (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nutrition Science (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Fodder In General (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Feed For Specific Animals (AREA)
- Dermatology (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261706164P | 2012-09-27 | 2012-09-27 | |
| PCT/US2013/062227 WO2014052780A2 (en) | 2012-09-27 | 2013-09-27 | Compositions and methods of use of an inappetance-controlling compound |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2015003564A true MX2015003564A (es) | 2015-11-16 |
Family
ID=50339468
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2015003564A MX2015003564A (es) | 2012-09-27 | 2013-09-27 | Composiciones y metodos de uso de un compuesto de control de inapetencia. |
| MX2022015141A MX2022015141A (es) | 2012-09-27 | 2015-03-19 | Composiciones y metodos de uso de un compuesto de control de inapetencia. |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2022015141A MX2022015141A (es) | 2012-09-27 | 2015-03-19 | Composiciones y metodos de uso de un compuesto de control de inapetencia. |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US11090292B2 (https=) |
| EP (3) | EP3524260B1 (https=) |
| JP (2) | JP6779618B2 (https=) |
| KR (6) | KR20250048114A (https=) |
| CN (2) | CN111419845A (https=) |
| AR (2) | AR092713A1 (https=) |
| AU (2) | AU2013323349B2 (https=) |
| BR (1) | BR112015006282B1 (https=) |
| CA (1) | CA2886091C (https=) |
| DK (1) | DK3524260T3 (https=) |
| ES (1) | ES2959427T3 (https=) |
| MX (2) | MX2015003564A (https=) |
| NZ (2) | NZ746394A (https=) |
| PL (1) | PL3524260T3 (https=) |
| PT (1) | PT3524260T (https=) |
| RU (1) | RU2648958C2 (https=) |
| TW (3) | TWI732158B (https=) |
| WO (1) | WO2014052780A2 (https=) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10975070B2 (en) | 2010-02-26 | 2021-04-13 | Raqualia Pharma Inc. | Ghrelin receptor agonist for treatment of cachexia |
| WO2013119800A1 (en) | 2012-02-07 | 2013-08-15 | Massachusetts Institute Of Technology | Use of antagonists of ghrelin or ghrelin receptor to prevent or treat stress-sensitive psychiatric illness |
| BR112015006282B1 (pt) | 2012-09-27 | 2021-11-23 | Aratana Therapeutics, Inc | Composições e usos de capromorelina para controle de inapetência |
| US9724396B2 (en) | 2013-03-15 | 2017-08-08 | Massachusetts Institute Of Technology | Use of antagonists of growth hormone or growth hormone receptor to prevent or treat stress-sensitive psychiatric illness |
| US9700591B2 (en) * | 2015-01-28 | 2017-07-11 | Aratana Therapeutics, Inc. | Compositions and methods for chronic use of a weight-gaining compound |
| US10317418B2 (en) | 2015-02-24 | 2019-06-11 | Massachusetts Institute Of Technology | Use of ghrelin or functional ghrelin receptor agonists to prevent and treat stress-sensitive psychiatric illness |
| WO2018089723A1 (en) * | 2016-11-11 | 2018-05-17 | Hill's Pet Nutrition, Inc. | Compositions and methods of pet food |
Family Cites Families (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US193273A (en) * | 1877-07-17 | Improvement in material for pulley-covers | ||
| JP2893901B2 (ja) * | 1990-09-07 | 1999-05-24 | 株式会社岐阜免疫研究所 | 動物用抗体含有油性ペースト製剤 |
| CA2095786A1 (en) * | 1992-05-08 | 1993-11-09 | Franco J. Vaccarino | Method of stimulating appetite |
| TW432073B (en) | 1995-12-28 | 2001-05-01 | Pfizer | Pyrazolopyridine compounds |
| DE60140285D1 (de) | 2000-05-31 | 2009-12-10 | Pfizer Prod Inc | Verwendung von Wachstumshormonsekretagoga zur Förderung der Beweglichkeit des Verdauungstrakts |
| EP1181933A3 (en) * | 2000-06-29 | 2002-04-10 | Pfizer Products Inc. | Use of growth hormone secretagogues for stimulating or increasing appetite |
| US8309603B2 (en) * | 2004-06-07 | 2012-11-13 | University Of Tennessee Research Foundation | SARMs and method of use thereof |
| US7491695B2 (en) * | 2003-06-18 | 2009-02-17 | Tranzyme Pharma Inc. | Methods of using macrocyclic modulators of the ghrelin receptor |
| US7476653B2 (en) | 2003-06-18 | 2009-01-13 | Tranzyme Pharma, Inc. | Macrocyclic modulators of the ghrelin receptor |
| JP2007532495A (ja) * | 2004-04-07 | 2007-11-15 | ガストロテック・ファルマ・アクティーゼルスカブ | グレリン欠乏を治療するための分泌促進薬の使用 |
| WO2006045313A2 (en) * | 2004-10-27 | 2006-05-04 | Gastrotech Pharma A/S | Uses of secretagogues for treatment of organ transplant patients |
| US8226973B2 (en) * | 2005-11-02 | 2012-07-24 | Nestec, S. A. | Isoflavone compositions for reducing accumulation of body fat in male mammals, and methods for their use |
| NZ571183A (en) * | 2006-03-13 | 2010-09-30 | Liat Mintz | Use of ghrelin splice variant for treating cachexia and/or anorexia and/or anorexia-cachexia and/or malnutrition and/or lipodystrophy and/or muscle wasting and/or appetite stimulation |
| US8299022B2 (en) | 2006-09-27 | 2012-10-30 | Ipsen Pharma S.A.S. | Analogs of ghrelin substituted at the N-terminal |
| JP2008127377A (ja) * | 2006-11-24 | 2008-06-05 | Jichi Medical Univ | Ｇｈｓ−ｒ作動薬を含有してなるメタボリックシンドローム又は高血圧症の予防・治療剤。 |
| US20080226802A1 (en) * | 2007-03-14 | 2008-09-18 | Concentrate Manufacturing Company Of Ireland | Beverage having natural sweeteners with one or more stevia components and source of berry |
| TWI429436B (zh) * | 2007-04-10 | 2014-03-11 | Helsinn Therapeutics Us Inc | 使用生長激素促泌素治療或預防嘔吐之方法 |
| RU2007129408A (ru) * | 2007-07-31 | 2009-02-10 | Игорь Николаевич Жирков (RU) | Способ выращивания поросят в период откорма |
| FR2920295B1 (fr) | 2007-09-05 | 2009-12-11 | Desvac | Dispositif d'injection de produits veterinaires a des volailles, comprenant un element de contention presentant une forme anatomique incluant des moyens de calage d'un os reperable |
| CN101854814B (zh) * | 2007-11-12 | 2013-07-31 | 三荣源有限公司 | 改善甜叶菊提取物甜味的方法 |
| EP2412713B1 (en) * | 2009-03-26 | 2016-11-30 | Takeda Pharmaceutical Company Limited | Pyrazole compound |
| US10975070B2 (en) | 2010-02-26 | 2021-04-13 | Raqualia Pharma Inc. | Ghrelin receptor agonist for treatment of cachexia |
| BR112015006282B1 (pt) | 2012-09-27 | 2021-11-23 | Aratana Therapeutics, Inc | Composições e usos de capromorelina para controle de inapetência |
-
2013
- 2013-09-27 BR BR112015006282-2A patent/BR112015006282B1/pt active IP Right Grant
- 2013-09-27 EP EP19161662.2A patent/EP3524260B1/en active Active
- 2013-09-27 EP EP13841455.2A patent/EP2906041A4/en not_active Withdrawn
- 2013-09-27 TW TW107142255A patent/TWI732158B/zh active
- 2013-09-27 NZ NZ746394A patent/NZ746394A/en unknown
- 2013-09-27 JP JP2015534747A patent/JP6779618B2/ja active Active
- 2013-09-27 RU RU2015114996A patent/RU2648958C2/ru active
- 2013-09-27 PT PT191616622T patent/PT3524260T/pt unknown
- 2013-09-27 KR KR1020257009208A patent/KR20250048114A/ko active Pending
- 2013-09-27 ES ES19161662T patent/ES2959427T3/es active Active
- 2013-09-27 TW TW109121986A patent/TW202106298A/zh unknown
- 2013-09-27 TW TW102135177A patent/TWI667024B/zh active
- 2013-09-27 KR KR1020217042990A patent/KR20220003640A/ko not_active Ceased
- 2013-09-27 AR ARP130103486A patent/AR092713A1/es not_active Application Discontinuation
- 2013-09-27 KR KR1020217001509A patent/KR20210009438A/ko not_active Ceased
- 2013-09-27 CA CA2886091A patent/CA2886091C/en active Active
- 2013-09-27 DK DK19161662.2T patent/DK3524260T3/da active
- 2013-09-27 WO PCT/US2013/062227 patent/WO2014052780A2/en not_active Ceased
- 2013-09-27 AU AU2013323349A patent/AU2013323349B2/en active Active
- 2013-09-27 NZ NZ707174A patent/NZ707174A/en active IP Right Revival
- 2013-09-27 PL PL19161662.2T patent/PL3524260T3/pl unknown
- 2013-09-27 CN CN202010001164.1A patent/CN111419845A/zh active Pending
- 2013-09-27 US US14/039,114 patent/US11090292B2/en active Active
- 2013-09-27 MX MX2015003564A patent/MX2015003564A/es active IP Right Grant
- 2013-09-27 KR KR1020157009647A patent/KR20150058345A/ko not_active Ceased
- 2013-09-27 KR KR1020197037811A patent/KR20190143484A/ko not_active Ceased
- 2013-09-27 CN CN201380061931.6A patent/CN105072909A/zh active Pending
- 2013-09-27 EP EP23191187.6A patent/EP4302825A3/en active Pending
- 2013-09-27 KR KR1020237019962A patent/KR20230097201A/ko not_active Ceased
-
2015
- 2015-03-19 MX MX2022015141A patent/MX2022015141A/es unknown
-
2016
- 2016-08-22 AU AU2016216741A patent/AU2016216741B2/en active Active
-
2018
- 2018-03-07 JP JP2018041063A patent/JP6796097B2/ja active Active
-
2021
- 2021-10-22 AR ARP210102942A patent/AR123902A2/es unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX373330B (es) | Composiciones y métodos que comprenden bupropion o compuestos relacionados y dextrometorfano. | |
| PH12017500070A1 (en) | Methods of treating cancer using tigit inhibitors and anti-cancer agents | |
| MX2015003564A (es) | Composiciones y metodos de uso de un compuesto de control de inapetencia. | |
| CL2015003801A1 (es) | Formulaciones de anticuerpos y metodos | |
| PH12016500511A1 (en) | Selective grp94 inhibitors and uses thereof | |
| GB2535876A (en) | Absorbent clumping animal litter compositions | |
| EA201692301A1 (ru) | Производные бороновой кислоты и их терапевтическое применение | |
| EA201590880A1 (ru) | Композиции и способы лечения протеинопатий | |
| UA117451C2 (uk) | Терапевтично активні сполуки і способи їх застосування | |
| PE20151727A1 (es) | Acido 2-aza-biciclo[2.2.1]heptano-3-carboxilico (bencil-ciano-metil)-amidas sustituidas inhibidores de catepsina c | |
| PH12015502649A1 (en) | Heterocyclic compounds as pest control agents | |
| AR089993A1 (es) | Macrociclos peptidomimeticos | |
| WO2014145159A3 (en) | Charge-engineered antibodies or compositions of penetration-enhanced targeting proteins and methods of use | |
| NZ708453A (en) | Germicidal compositions comprising carboxylic acid mixture and use as topical disinfectants | |
| MX2019006893A (es) | Inhibidores heterociclicos de mct4. | |
| BR112017026535A2 (pt) | composto de fórmula estrutural i, enantiômero isolado, composição farmacêutica, método para inibir atividade do transportador de monocarboxilato mct4, método para inibir seletivamente atividade do transportador de monocarboxilato mct4, método para tratar um distúrbio mediado por transportador de monocarboxilato mct4 e uso de um composto | |
| MX364800B (es) | Tilmicosina de accion prolongada mejorada y el uso de la misma en el tratamiento del complejo respiratorio bovino (crb) y en el periodo de la vaca seca. | |
| EA201690323A1 (ru) | Способы лечения заболеваний уха у детей | |
| EA201692481A1 (ru) | Комбинация, содержащая глюкокортикоид и edo-s101 | |
| MX372642B (es) | Un metodo para controlar plagas que habitan en la superficie del agua. | |
| AR097143A1 (es) | Composición alimenticia mineral para lamer para rumiantes y método para prepararla | |
| EA201591507A1 (ru) | Лечение рассеянного склероза лахинимодом | |
| MX2016007356A (es) | Composicion para administracion oral de agentes bioactivos. | |
| MX2020001428A (es) | Composiciones de grapiprant y metodos para usar las mismas. | |
| MX383741B (es) | Composiciones y métodos para el uso crónico de un compuesto para aumentar el peso. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant or registration |